Cardiology Board Review in ICDs

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Goals[edit | edit source]

• Commit to memory the indications for ICD placement following STEMI
• The majority, but not all trials indicate that there is a benefit to placement of an ICD after the first three months of survival
• DINAMIT and IRIS did not show a benefit of ICD placement during the first 3 months after STEMI
• Likewise, it should be noted that MADITT II excluded patients who had an MI or revascularization within the preceding 40 days.
• Amiodarone was associated with a reduction in arrhythmic death among patients with an LVEF of <40% following STEMI, but all cause mortality was not imprlved in the CAMIAT trial.
• An external cardiac defibrillator vest can be prescribed in high risk patients with a low ejection fraction while the patient is awaiting assessment of their LVEF at 3 months.

Template:WH Template:WS